Trial: Vitamin K Supplement Curbs Coronary Atherosclerosis

(MedPage Today) -- Menaquinone-7 (MK-7) supplementation modestly slowed the progression of coronary artery calcification (CAC) for patients in the placebo-controlled VitaK-CAC trial. Among people with existing chronic coronary atherosclerosis...
Source
MedPage Today
Opens original article in a new tab



